About Imbed Biosciences
Imbed Biosciences is a private company based in Middleton, Wisconsin. It has reported $22,270,587 raised in eight offerings on Form D since April 2014. Its chief executive is Elizabeth Taylor.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 14, 2023 | Dec 29, 2023 | $3,500,000of $3.6M target | 1 | $3.5M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| May 17, 2023 | May 31, 2023 | $2,500,000of $6.0M target | 2 | $1.2M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 11, 2021 | Nov 24, 2021 | $7,892,399of $14.2M target | 37 | $213K | EquityRule 506(b) | Form D ↗ |
| Jun 3, 2020 | Jun 18, 2020 | $1,494,000of $1.5M target | 18 | $83,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 12, 2018 | Oct 29, 2018amended Oct 7, 2019 | $4,028,965of $4.1M target | 47 | $85,723 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 14, 2017 | Dec 28, 2017 | $1,571,948of $1.6M target | 11 | $142K | Equity, OptionsRule 506(b) | Form D ↗ |
| Aug 5, 2016 | Aug 18, 2016 | $600,000of $750K target | 3 | $200K | Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 11, 2014 | Apr 24, 2014amended Sep 4, 2014 | $683,275of $1.0M target | 8 | $85,409 | Equity, Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Total, eight offerings | $22,270,587 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Imbed Biosciences's Form D filed Dec 29, 2023.
PF
Philip Foster
Director
AA
Ankit Agarwal
Executive officer and director
WD
Walter Dewey
Director
DG
David Guinther
Director
JB
Jonathan Black
Director
ET
Elizabeth Taylor
Chief Executive Officer
Earlier filings also listed Michael Schurr (director, last listed Nov 2021), Jeff Hanson (director, last listed Nov 2021), Robert Beckman (director, last listed Oct 2019) and Nicholas Abbott (executive officer and director, last listed Oct 2019).